Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 70518-2022

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-2022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Bupropion Hydrochloride extended-release tablet, 150 mg strength, containing 90 tablets. The tablet is described as round, white, with imprint L015. The label includes storage instructions, manufacturer Lupin Pharma, and repackager RemedyRepack Inc. Contact information and NDC 70518-2022-02 are also shown.*

FDA Label Image

Efb9b587 A68d 4c3e A0e1 7e5caac736c3 01

Chemical structure of bupropion hydrochloride showing its molecular framework including a chlorophenyl group, carbonyl group, and tert-butylamino substituent with hydrochloride indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.